Loading organizations...
Loading organizations...
Clinical-stage biotechnology developing innovative cancer cell therapies.
Acepodia has raised $156.0M across 2 funding rounds.
Acepodia has raised $156.0M in total across 2 funding rounds.
Acepodia has raised $156.0M in total across 2 funding rounds.
Acepodia's investors include Samuel Chen, 8VC, CDIB Capital Group, DEFTA Partners, Wayne Holman.
Acepodia has raised $156.0M across 2 funding rounds. Most recently, it raised $109.0M Series C in December 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 2, 2021 | $109.0M Series C | Samuel Chen | |
| Mar 16, 2021 | $47.0M Series B | 8VC, CDIB Capital Group, DEFTA Partners, Wayne Holman |